Pentamidine Dosage: A Base/Salt Confusion

Pentamidine has a long history in the treatment of human African trypanosomiasis (HAT) and leishmaniasis. Early guidelines on the dosage of pentamidine were based on the base-moiety of the two different formulations available. Confusion on the dosage of pentamidine arose from a different labelling of the two available products, either based on the salt or base moiety available in the preparation. We provide an overview of the various guidelines concerning HAT and leishmaniasis over the past decades and show the confusion in the calculation of the dosage of pentamidine in these guidelines and the subsequent published reports on clinical trials and reviews. At present, only pentamidine isethionate is available, but the advised dosage for HAT and leishmaniasis is (historically) based on the amount of pentamidine base. In the treatment of leishmaniasis this is probably resulting in a subtherapeutic treatment. There is thus a need for a new, more transparent and concise guideline concerning the dosage of pentamidine, at least in the treatment of HAT and leishmaniasi

The Unknown Risk of Vertical Transmission in Sleeping Sickness—A Literature Review

Children with human African trypanosomiasis (HAT) present with a range of generally non-specific symptoms. Late diagnosis is frequent with often tragic outcomes. Trypanosomes can infect the foetus by crossing the placenta. Unequivocal cases of congenital infection that have been reported include newborn babies of infected mothers who were diagnosed with HAT in the first 5 days of life and children of infected mothers who had never entered an endemic country themselves

Applications of yeast flocculation in biotechnological processes

A review on the main aspects associated with yeast flocculation and its application in biotechnological processes is presented. This subject is addressed following three main aspects – the basics of yeast flocculation, the development of “new” flocculating yeast strains and bioreactor development. In what concerns the basics of yeast flocculation, the state of the art on the most relevant aspects of mechanism, physiology and genetics of yeast flocculation is reported. The construction of flocculating yeast strains includes not only the recombinant constitutive flocculent brewer’s yeast, but also recombinant flocculent yeast for lactose metabolisation and ethanol production. Furthermore, recent work on the heterologous β-galactosidase production using a recombinant flocculent Saccharomyces cerevisiae is considered. As bioreactors using flocculating yeast cells have particular properties, mainly associated with a high solid phase hold-up, a section dedicated to its operation is presented. Aspects such as bioreactor productivity and culture stability as well as bioreactor hydrodynamics and mass transfer properties of flocculating cell cultures are considered. Finally, the paper concludes describing some of the applications of high cell density flocculation bioreactors and discussing potential new uses of these systems.Fundação para a Ciência e a Tecnologia (FCT) – PRAXIS XXI - BD11306/97

Toward a theory of the general-anesthetic-induced phase transition of the cerebral cortex. II. Numerical simulations, spectral entropy, and correlation times

In our two recent papers [M.L. Steyn-Ross et al., Phys. Rev. E 60, 7299 (1999); 64, 011917 (2001)] we presented clinical evidence for a general anesthetic-induced phase change in the cerebral cortex, and showed how the significant features of the cortical phase change (biphasic power surge, spectral energy redistribution, “heat capacity” divergence), could be explained using a stochastic single-macrocolumn model of the cortex. The model predictions were based on rather strong “adiabatic” assumptions which assert that the mean-field excitatory and inhibitory macrocolumn voltages are “slow” variables whose equilibration times are much longer than those of the input “currents” that drive the macrocolumn. In the present paper we test the adiabatic assumption by running numerical simulations of the stochastic differential equations. These simulations confirm the number and nature of the steady-state solutions, the growth of fluctuation power at transition, and the redistribution of spectral energy towards lower frequencies. We use spectral entropy to quantify these changes in the power spectral density, and to show that the spectral entropy should decrease markedly at the point of transition. This prediction agrees with recent clinical findings by Viertiö-Oja and colleagues [J. Clinical Monitoring Computing 16, 60 (2000)]. Our modeling work shows that there is an inverse relationship between spectral entropy H and correlation time T of the soma-voltage fluctuations: H∝- (ln T). In a theoretical analysis we prove that this proportionality becomes exact for an ideal Lorentzian process. These findings suggest that by monitoring the changes in EEG correlation time, it should be possible to track changes in the state of patient consciousness